activ
site
proteinas
coronaviru
identifi
compar
crystal
structur
human
porcin
coronaviru
inhibitor
main
protein
rhinoviru
could
bind
human
coronaviru
select
refer
molecular
dock
databas
screen
tigand
two
databas
use
search
potenti
lead
structur
molecular
dock
severai
structur
natur
product
acdsc
databas
found
lower
bind
free
energi
structur
similar
hydrophob
complementari
electrostat
potenti
hydrogen
bond
acceptor
donor
show
strategi
antisar
drug
design
base
molecular
dock
databas
screen
feasibl
first
case
sever
acut
respiratori
syndrom
sar
identifi
novemb
guangdong
provinc
china
march
put
caus
sar
identifi
new
coronaviru
sarscov
member
coronovirida
famili
envelop
positivestrand
rna
virus
broad
host
rang
length
genom
sequenc
coronavirus
kb
could
encod
put
protein
includ
main
proteinas
mp
also
call
c
l
nucleocapsid
n
spike
membran
small
envelop
e
viral
main
proteinas
c
l
control
activ
coronaviru
replic
complex
attract
target
therapi
drug
larg
number
compound
synthes
separ
order
find
antisar
lead
compound
v
l
screen
advantag
search
lead
structur
cheaper
real
experi
calcul
could
perform
compound
yet
purchas
synthes
virtual
screen
use
wide
fmd
initi
lead
structur
larg
compound
collect
therefor
amount
work
done
search
inhibitor
studi
use
molecular
dock
screen
filter
screen
sever
type
da
e
l
acxn
tabas
inhous
natur
product
acd
screen
databas
interest
result
report
crystal
structur
main
proteinas
human
coronaviru
extract
brookhaven
protein
databank
pdb
code
hilgenfeld
et
report
inhibitor
complex
porcin
coronaviru
found
sar
coronaviru
sarscov
main
proteinas
reveal
remark
degre
conserv
substratebind
site
porcin
coronaviru
pdb
code
porcin
coronaviru
ilvo
align
two
structur
routin
align
homolog
found
homolog
ratio
two
amino
acid
sequenc
region
bind
site
show
region
substrat
bind
site
remark
conserv
could
identifi
activ
site
human
coronaviru
testifi
mean
routin
molcad
hilgenfeld
ef
report
rhinoviru
prepar
receptor
hibitor
may
molfi
make
use
sar
therapi
sinc
see
figur
enter
chical
trial
inhibitor
human
rhinovirus
reason
select
screen
refer
molecular
dynam
use
optim
structur
tripo
forc
fieldg
partial
atom
charg
calcul
kollmanallatom
approxim
gasteigerhiickel
two
type
inhibitor
set
caviti
bind
site
calcul
perform
workstat
sgi
origin
cpu
dock
energi
screen
f
activ
site
match
electrostat
potenti
match
hydrophob
match
figur
structur
refer
compound
hydrogen
bond
match
u
ok
suitabl
softwar
perform
autom
dock
ligand
macromolecular
protein
receptor
individu
compon
program
includ
autotor
autogrid
autodock
autotor
defin
bond
ligand
rotat
affect
degre
freedom
ligand
thu
complex
comput
autogrid
precalcul
threedimension
grid
interact
energi
base
macromolecular
target
use
amber
forc
field
autodock
begin
process
simul
first
ligand
move
randomli
one
six
degre
freedom
either
translat
rotat
energi
new
ligand
state
calcul
energi
new
state
lower
old
state
new
one
automat
accept
next
step
dock
dock
process
maximum
conform
consid
compound
default
set
conform
bind
free
energi
import
criterion
reliabl
virtual
screen
investig
ligand
locat
activ
site
anoth
necessari
condit
screen
result
hand
hydrophob
charact
anoth
import
factor
drug
design
reflect
whether
drug
molecul
could
reach
surfac
protein
usual
estim
estedwat
distribut
coeffici
log
p
therefor
studi
log
p
use
anoth
criterion
virtual
screen
process
virtual
screen
also
think
standard
electrostat
potenti
format
hydrogen
bond
featur
use
fdter
virtual
screen
flow
chart
virtual
screen
shown
figur
activ
site
main
protein
shown
figur
contain
l
pocket
pocket
caviti
canal
molecular
modehg
suggest
avail
rhinoviru
inhibitor
may
modiu
addcharg
align
structur
tie
make
use
treat
r
select
refer
virtual
creen
bind
free
energi
kjmol
studi
dock
complex
illustr
figur
dock
complex
hydrophob
electrostat
interact
residu
one
hydrogen
bond
residu
gli
studi
natur
product
structur
select
inhous
databas
contain
structur
collect
recent
literatur
princip
tcm
pharmaceut
compon
prescreen
structur
use
filter
firstli
select
compound
macro
lacton
align
bind
free
energi
calcul
consid
bind
free
energi
structur
less
wmol
potenti
lead
structur
screen
result
present
figur
ratio
potenti
lead
structur
total
screen
structur
show
good
refer
structur
screenkg
screen
strategi
feasibl
among
potenti
lead
structur
structur
bind
receptor
activ
site
bind
free
energi
log
p
size
ring
comment
gather
tabl
influenc
hydrophob
import
log
p
valu
structur
approach
ring
structur
member
cycl
size
suggest
suitabl
larg
ring
could
locat
activ
site
receptor
figur
exampl
dock
complex
structur
structur
locat
activ
site
electrostat
potenti
complementari
could
increas
bind
affin
ligand
receptor
interact
favor
bioactiv
one
hydrogen
bond
oxygen
atom
c
residu
two
hydrogen
bond
nh
residu
two
oxygen
atom
carbonyl
link
hydrogen
bond
residu
investig
complex
four
hydrogen
bond
ligand
residu
also
one
hydrogen
bond
residu
residu
respect
hydrogen
bond
seem
favour
activ
includ
function
group
sulphon
molecular
volum
less
natur
product
structur
antivir
activ
scaffold
flexibl
activ
site
might
make
differ
size
molecul
locat
posit
dock
inhous
databas
finish
screen
acdsc
databas
perform
compound
select
limit
molecular
weight
condit
dock
research
done
result
virtual
screen
organ
tabl
complex
shown
figur
could
bind
receptor
tightli
structur
figur
coinplex
l
g
present
novel
approach
base
molecular
dock
databas
screen
search
inhibitor
sarscov
first
step
iden
activ
site
compar
crystal
structur
human
porcin
coronaviru
sinc
could
inhibit
main
protein
rhinoviru
select
screen
refer
dock
research
prescreen
databas
compound
built
compound
screen
put
pocket
known
antivir
inhibitor
like
could
screen
within
bestscor
list
show
screen
strategi
feasibl
bind
free
energi
kjmol
sever
structur
natur
product
acdsc
databas
found
lower
bind
free
energi
structur
similar
hydrophob
electrostat
potenti
hydrogen
bond
acceptor
donor
complementari
structur
potenti
lead
inhibitor
antisar
synthesi
bioactiv
compound
done
later
